* PolyPid Ltd PYPD.OQ PYPD.O is expected to show no
change in
quarterly revenue when it reports results on February 14 for
the period ending December 31 2023
*
* LSEG's mean analyst estimate for PolyPid Ltd is for a
loss of
$3.58 per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for PolyPid Ltd
is
$13.00, above its last closing price of $6.92.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT ESTIMATE MET, SE %
E® MISSED
Sep. 30 2023 -3.99 -4.16 -3.40 Beat 18.3
Jun. 30 2023 -6.90 -9.18 -3.90 Beat 57.5
Mar. 31 2023 -9.50 -7.79 -8.40 Missed -7.8
Dec. 31 2022 -12.05 -12.36 -9.60 Beat 22.3
Sep. -16.50 -16.22 -14.40 Beat 11.2
30 2022
Jun. 30 2022 -18.28 -18.55 -18.30 Beat 1.3
Mar. 31 2022 -19.36 -19.20 -18.90 Beat 1.6
Dec. 31 2021 -17.24 -16.85 -21.30 Missed -26.4
This summary was machine generated February 12 at 15:14 GMT.
All figures in US dollars unless otherwise stated. (For
questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)